Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD). (2018). Biomolecules and Biomedicine, 18(3), 260-267. https://doi.org/10.17305/bjbms.2018.2493